{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T22:52:57Z","timestamp":1787266377536,"version":"build-2736575974"},"reference-count":32,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2024,8,2]]},"DOI":"10.1080\/03007995.2024.2368175","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T16:18:26Z","timestamp":1718641106000},"page":"1369-1378","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Overall survival of patients with CLL treated with ibrutinib in the first line compared to second-line ibrutinib after chemotherapy\/chemoimmunotherapy"],"prefix":"10.1080","volume":"40","author":[{"given":"Tadeusz","family":"Robak","sequence":"first","affiliation":[{"name":"Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doubek","sequence":"additional","affiliation":[{"name":"Internal Medicine \u2013 Hematology and Oncology Department, University Hospital Brno","place":["Brno, Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Ferrant","sequence":"additional","affiliation":[{"name":"Department of Hematology, H\u00f4pital Lyon-Sud","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Diels","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutica NV","place":["Beerse, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liva","family":"Andersone","sequence":"additional","affiliation":[{"name":"UAB \u201cJOHNSON & JOHNSON\u201d filiale Latvija","place":["Riga, Latvia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Wilbertz","sequence":"additional","affiliation":[{"name":"Janssen-Cilag GmbH","place":["Neuss, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nollaig C.","family":"Healy","sequence":"additional","affiliation":[{"name":"Janssen Sciences Ireland UC","place":["Cork, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Neumayr","sequence":"additional","affiliation":[{"name":"Pharmacyclics, an AbbVie Company","place":["Sunnyvale, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzy","family":"van Sanden","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutica NV","place":["Beerse, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,7]]},"reference":[{"key":"e_1_3_5_2_1","volume-title":"Janssen-Cilag International NV","author":"IMBRUVICA\u00ae (ibrutinib) [SmPC]","year":"2023","unstructured":"IMBRUVICA\u00ae (ibrutinib) [SmPC]. Janssen-Cilag International NV. Beerse, Belgium; 2023."},{"key":"e_1_3_5_3_1","volume-title":"Pharmacyclics LLC","author":"IMBRUVICA\u00ae (ibrutinib) [prescribing information]","year":"2023","unstructured":"IMBRUVICA\u00ae (ibrutinib) [prescribing information]. Pharmacyclics LLC. Sunnyvale, CA: Janssen Biotech, Inc., Horsham, PA; 2023."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.019"},{"key":"e_1_3_5_5_1","volume-title":"L\u00e9\u010debn\u00e9 postupy v hematologii 2023 [Treatments in hematology 2023]","author":"\u0160pa\u010dek M","year":"2023","unstructured":"\u0160pa\u010dek M, \u0160imkovi\u010d M, Posp\u00ed\u0161ilov\u00e1 \u0160, et\u00a0al. 7. Chronick\u00e1 lymfocyt\u00e1rn\u00ed leukemie [Chronic lymphocytic leukemia]. In: Doubek M, Mayer J, editors. L\u00e9\u010debn\u00e9 postupy v hematologii 2023 [Treatments in hematology 2023]. Brno, Czech Republic: \u010cesk\u00e1 hematologick\u00e1 spole\u010dnost \u010cLS JEP; 2023."},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000801"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01485-x"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00293-5"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006434"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv254"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-022-01141-x"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235996"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509388"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2017-0046"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-019-03830-8"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341x.2000.00779.x"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X13520192"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200009000-00012"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0145-y"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-019-00685-x"},{"key":"e_1_3_5_21_1","volume-title":"Causal inference: what if","author":"Hern\u00e1n MA","year":"2020","unstructured":"Hern\u00e1n MA, Robins JM. Causal inference: what if. Boca Raton, FL: Chapman & Hall\/CRC; 2020."},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9171"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq439"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147927"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812836"},{"issue":"4","key":"e_1_3_5_27_1","first-page":"1121","article-title":"Clinical endpoints in oncology - a primer","volume":"11","author":"Delgado A","year":"2021","unstructured":"Delgado A, Guddati AK. Clinical endpoints in oncology - a primer. Am J Cancer Res. 2021;11(4):1121\u20131131.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-163257"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014960"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1957871"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01991-5"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26779"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-155649"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2024.2368175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:39:28Z","timestamp":1741628368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2024.2368175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,2]]}},"alternative-id":["10.1080\/03007995.2024.2368175"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2024.2368175","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}